Indian Company Master Data Made Simple
Search:
MCA
GSTIN
LEI
Udyam
Directors
36+ lakh companies in our registry
Glaxosmithkline Pharmaceuticals Limited
Since its incorporation in 1924, Glaxosmithkline Pharmaceuticals Limited has accumulated more than 10 decades of experience. Its CIN is L24239MH1924PLC001151, with registration number 1151. Glaxosmithkline Pharmaceuticals Limited is identified as company limited by shares in the corporate registry. Authorized share capital stands at ₹180.00 crore. Glaxosmithkline Pharmaceuticals Limited reports paid-up capital of ₹169.41 crore.
The main line of business is manufacture of other chemical products. Registered under the jurisdiction of Mumbai. The official address of incorporation is Gsk House, Dr Annie Besant Road Worli, Mumbai City, Mumbai, Maharashtra, India, 400030. The entity is active and conducting operations. Glaxosmithkline Pharmaceuticals Limited is registered with the PAN code AAACG4414B. The firm is registered with LEI code 3358002TNSC1U2DWNY52. Glaxosmithkline Pharmaceuticals Limited can be contacted at askus@gsk.com. Senior management roles are held by Juby Chandy (CFO).
Company Overview
- CIN
- Date of Incorporation
- 12/11/1924
- Company Status
- Active
- RoC
- Mumbai
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- LEI Status
- Issued
- Authorized Capital
- ₹1,80,00,00,000.00
- Paid up Capital
- ₹1,69,40,60,340.00
- Activity
- Manufacture of other chemical products
- askus@gsk.com
- PAN
GST Numbers
| State | GST Number | Status |
|---|---|---|
| Assam | 18AAACG4414B2Z6 | Inactive |
| 18AAACG4414B1Z7 | Active | |
| 18AAACG4414B3Z5 | Inactive | |
| Andhra Pradesh | 37AAACG4414B1Z7 | Active |
| Bihar | 10AAACG4414B1ZN | Active |
| Chandigarh | 04AAACG4414B1ZG | Active |
| Chhattisgarh | 22AAACG4414B1ZI | Active |
| Delhi | 07AAACG4414B1ZA | Active |
| Goa | 30AAACG4414B1ZL | Active |
| Gujarat | 24AAACG4414B1ZE | Active |
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| INE159A01016 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED EQ | - | 12/10/2026 | GLAXOSMITHKLINE/SH VTG | ESVUFN |
| IN8159A01015 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED EQ LISTING/TRADING APPROVAL AWAITED | - | 12/10/2026 | GLAXOSMITHKLINE/SH VTG | ESVUFN |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net PPE | ₹30,644.44L | ₹28,385.87L | ₹31,073.18L | ₹31,511.87L | ₹0.00L |
| Gross PPE | ₹62,636.79L | ₹57,947.64L | ₹59,386.15L | ₹57,066.30L | ₹0.00L |
| Inventory | ₹45,755.44L | ₹48,173.68L | ₹52,504.82L | ₹45,997.04L | ₹0.00L |
| Total Debt | ₹3,327.22L | ₹995.12L | ₹1,866.50L | ₹1,553.92L | ₹0.00L |
| Common Stock | ₹16,940.60L | ₹16,940.60L | ₹16,940.60L | ₹16,940.60L | ₹0.00L |
| Share Issued | ₹1,694.06L | ₹1,694.06L | ₹1,694.06L | ₹1,694.06L | ₹0.00L |
| Total Assets | ₹4,32,386.64L | ₹4,10,806.55L | ₹3,55,661.75L | ₹3,32,658.48L | ₹0.00L |
| Capital Stock | ₹16,940.60L | ₹16,940.60L | ₹16,940.60L | ₹16,940.60L | ₹0.00L |
| Current Assets | ₹3,60,706.41L | ₹3,40,988.08L | ₹2,79,841.86L | ₹2,49,426.45L | ₹0.00L |
| Prepaid Assets | ₹5,550.80L | ₹4,282.27L | ₹4,269.94L | ₹2,686.13L | ₹0.00L |
| Working Capital | ₹1,82,796.08L | ₹1,50,472.62L | ₹1,27,347.25L | ₹1,16,789.44L | ₹0.00L |
| Invested Capital | ₹2,26,741.32L | ₹1,95,131.07L | ₹1,77,763.97L | ₹1,74,127.30L | ₹0.00L |
| Other Properties | ₹27,351.00L | ₹26,954.00L | ₹1,744.36L | ₹1,379.94L | ₹0.00L |
| Retained Earnings | ₹1,38,310.87L | ₹1,05,863.16L | ₹87,643.52L | ₹81,149.14L | ₹0.00L |
| Common Stock Equity | ₹2,26,741.32L | ₹1,95,131.07L | ₹1,77,763.97L | ₹1,74,127.30L | ₹0.00L |
| Net Tangible Assets | ₹2,26,085.69L | ₹1,93,797.90L | ₹1,75,408.59L | ₹1,70,718.22L | ₹0.00L |
| Tangible Book Value | ₹2,26,085.69L | ₹1,93,797.90L | ₹1,75,408.59L | ₹1,70,718.22L | ₹0.00L |
| Current Liabilities | ₹1,77,910.33L | ₹1,90,515.46L | ₹1,52,494.61L | ₹1,32,637.01L | ₹0.00L |
| Long Term Provisions | ₹14,131.52L | ₹14,131.52L | ₹24,746.45L | ₹25,480.32L | ₹0.00L |
| Stockholders Equity | ₹2,26,741.32L | ₹1,95,131.07L | ₹1,77,763.97L | ₹1,74,127.30L | ₹0.00L |
| Other Equity Interest | -₹1,570.78L | -₹1,487.55L | -₹900.53L | -₹167.72L | ₹0.00L |
| Total Capitalization | ₹2,26,741.32L | ₹1,95,131.07L | ₹1,77,763.97L | ₹1,74,127.30L | ₹0.00L |
| Investment Properties | ₹65.56L | ₹78.33L | ₹91.81L | ₹106.19L | ₹0.00L |
| Ordinary Shares Number | ₹1,694.06L | ₹1,694.06L | ₹1,694.06L | ₹1,694.06L | ₹0.00L |
| Other Intangible Assets | ₹655.63L | ₹1,333.17L | ₹2,355.38L | ₹3,409.08L | ₹0.00L |
| Other Non Current Assets | ₹23.62L | ₹42.80L | ₹60.60L | ₹107.74L | ₹0.00L |
| Total Non Current Assets | ₹71,680.23L | ₹69,818.47L | ₹75,819.89L | ₹83,232.03L | ₹0.00L |
| Cash And Cash Equivalents | ₹1,10,205.06L | ₹53,884.77L | ₹6,417.12L | ₹3,494.09L | ₹0.00L |
| Construction In Progress | ₹3,292.57L | ₹1,431.99L | ₹1,392.96L | ₹2,031.18L | ₹0.00L |
| Accumulated Depreciation | -₹31,992.35L | -₹29,561.77L | -₹28,312.97L | -₹25,554.43L | ₹0.00L |
| Additional Paid In Capital | ₹262.00L | ₹262.00L | ₹262.00L | ₹262.00L | ₹0.00L |
| Other Short Term Investments | ₹1,65,429.16L | ₹1,95,925.59L | ₹1,79,265.20L | ₹1,61,917.88L | ₹0.00L |
| Other Non Current Liabilities | ₹0.39L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Machinery Furniture Equipment | ₹44,400.92L | ₹44,009.06L | ₹44,885.82L | ₹42,443.79L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹655.63L | ₹1,333.17L | ₹2,355.38L | ₹3,409.08L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹2,26,741.32L | ₹1,95,131.07L | ₹1,77,763.97L | ₹1,74,127.30L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹2,05,645.32L | ₹2,15,675.48L | ₹1,77,897.78L | ₹1,58,531.18L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹1,599.90L | ₹745.92L | ₹1,219.59L | ₹1,208.38L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹1,727.32L | ₹249.20L | ₹646.91L | ₹345.54L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹2,75,634.22L | ₹2,49,810.36L | ₹1,85,682.32L | ₹1,65,411.97L | ₹0.00L |
| Total Non Current Liabilities Net Minority Interest | ₹27,734.99L | ₹25,160.02L | ₹25,403.17L | ₹25,894.17L | ₹0.00L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Free Cash Flow | ₹84,802.04L | ₹1,26,517.58L | ₹55,079.40L | ₹44,018.63L | ₹0.00L |
| Changes In Cash | ₹56,320.29L | ₹47,467.65L | ₹2,923.03L | -₹25,124.62L | ₹0.00L |
| End Cash Position | ₹1,10,205.06L | ₹53,884.77L | ₹6,417.12L | ₹3,494.09L | ₹0.00L |
| Financing Cash Flow | -₹73,707.84L | -₹76,942.02L | -₹56,149.69L | -₹1,54,332.30L | ₹0.00L |
| Investing Cash Flow | ₹39,698.17L | -₹4,580.07L | ₹871.17L | ₹80,785.14L | ₹0.00L |
| Operating Cash Flow | ₹90,329.96L | ₹1,28,989.74L | ₹58,201.55L | ₹48,422.54L | ₹0.00L |
| Capital Expenditure | -₹5,527.92L | -₹2,472.16L | -₹3,122.15L | -₹4,403.91L | ₹0.00L |
| Beginning Cash Position | ₹53,884.77L | ₹6,417.12L | ₹3,494.09L | ₹28,618.71L | ₹0.00L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| EBIT | ₹1,40,874.53L | ₹1,26,119.21L | ₹81,798.66L | ₹83,821.22L | ₹0.00L |
| EBITDA | ₹1,47,518.94L | ₹1,32,798.46L | ₹88,766.62L | ₹90,397.94L | ₹0.00L |
| Net Income | ₹1,03,598.24L | ₹92,758.29L | ₹58,996.10L | ₹61,068.68L | ₹1,69,472.00L |
| Gross Profit | ₹2,38,595.00L | ₹2,25,300.06L | ₹2,02,192.23L | ₹1,86,765.57L | ₹0.00L |
| Pretax Income | ₹1,40,601.30L | ₹1,25,987.84L | ₹81,618.79L | ₹83,640.00L | ₹0.00L |
| Tax Provision | ₹37,003.06L | ₹33,229.55L | ₹22,622.69L | ₹22,875.78L | ₹0.00L |
| Total Revenue | ₹3,80,755.35L | ₹3,72,603.47L | ₹3,44,177.08L | ₹3,22,637.87L | ₹3,27,803.00L |
| Cost Of Revenue | ₹1,42,160.35L | ₹1,47,303.41L | ₹1,41,984.85L | ₹1,35,872.30L | ₹0.00L |
| Total Expenses | ₹2,55,998.37L | ₹2,61,168.50L | ₹2,60,328.52L | ₹2,47,795.23L | ₹0.00L |
| Interest Income | ₹5,672.78L | ₹7,137.93L | ₹6,785.03L | ₹6,981.19L | ₹0.00L |
| Interest Expense | ₹273.23L | ₹131.37L | ₹179.87L | ₹181.22L | ₹0.00L |
| Operating Income | ₹1,24,756.98L | ₹1,11,434.97L | ₹83,848.56L | ₹74,842.64L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | ₹1,37,497.97L | ₹1,25,515.58L | ₹98,161.60L | ₹87,414.10L | ₹0.00L |
| Normalized Income | ₹96,214.79L | ₹87,396.28L | ₹65,787.03L | ₹58,596.16L | ₹0.00L |
| Operating Expense | ₹1,13,838.02L | ₹1,13,865.09L | ₹1,18,343.67L | ₹1,11,922.93L | ₹0.00L |
| Operating Revenue | ₹3,80,755.35L | ₹3,72,603.47L | ₹3,44,177.08L | ₹3,22,637.87L | ₹0.00L |
| Net Interest Income | ₹5,399.55L | ₹7,006.56L | ₹6,605.16L | ₹6,799.97L | ₹0.00L |
| Total Unusual Items | ₹10,020.97L | ₹7,282.88L | -₹9,394.98L | ₹2,983.84L | ₹0.00L |
| Other Operating Expenses | ₹22,628.21L | ₹27,248.66L | ₹26,872.60L | ₹27,289.63L | ₹0.00L |
| Reconciled Depreciation | ₹6,644.41L | ₹6,679.25L | ₹6,967.96L | ₹6,576.72L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹1,42,160.35L | ₹1,47,303.41L | ₹1,41,984.85L | ₹1,35,872.30L | ₹0.00L |
| Rent Expense Supplemental | ₹198.14L | ₹197.68L | ₹200.52L | ₹209.79L | ₹0.00L |
| Tax Effect Of Unusual Items | ₹2,637.52L | ₹1,920.87L | -₹2,604.05L | ₹815.78L | ₹0.00L |
| Interest Income Non Operating | ₹5,672.78L | ₹7,137.93L | ₹6,785.03L | ₹6,981.19L | ₹0.00L |
| Selling And Marketing Expense | ₹18,841.95L | ₹18,759.68L | ₹17,977.39L | ₹16,625.79L | ₹0.00L |
| Interest Expense Non Operating | ₹273.23L | ₹131.37L | ₹179.87L | ₹181.22L | ₹0.00L |
| Net Income Common Stockholders | ₹1,03,598.24L | ₹92,758.29L | ₹58,996.10L | ₹61,068.68L | ₹0.00L |
| Net Income Continuous Operations | ₹1,03,598.24L | ₹92,758.29L | ₹58,996.10L | ₹60,764.22L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | ₹1,03,598.24L | ₹92,758.29L | ₹58,996.10L | ₹61,068.68L | ₹0.00L |
| General And Administrative Expense | ₹6,074.00L | ₹5,168.28L | ₹4,862.94L | ₹4,081.94L | ₹0.00L |
| Selling General And Administration | ₹24,915.95L | ₹23,927.96L | ₹22,840.33L | ₹20,707.73L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | ₹10,020.97L | ₹7,282.88L | -₹9,394.98L | ₹2,983.84L | ₹0.00L |
| Net Non Operating Interest Income Expense | ₹5,399.55L | ₹7,006.56L | ₹6,605.16L | ₹6,799.97L | ₹0.00L |
| Net Income Including Noncontrolling Interests | ₹1,03,598.24L | ₹92,758.29L | ₹58,996.10L | ₹61,068.68L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | ₹1,03,598.24L | ₹92,758.29L | ₹58,996.10L | ₹61,068.68L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | ₹1,03,598.24L | ₹92,758.29L | ₹58,996.10L | ₹60,764.22L | ₹0.00L |
Company Performance (FY22–FY26)
₹3.8 K Cr₹2.9 K Cr₹1.9 K Cr₹951.9 Cr₹0
FY22FY23FY24FY25FY26
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 01/11/2001 | Ajay Avinash Nadkarni | *****4414B | Company Secretary | |
| 27/07/2009 | Sundaram Damodarannair | 00016304 | Director | View other directorships |
| 28/10/2010 | Pradeep Vasudeo Bhide | 03304262 | Director | View other directorships |
| 04/11/2011 | Anami Narayan Prema Roy | 01361110 | Director | View other directorships |
| 07/04/2017 | Subesh Ronald Williams | 07786724 | Director | View other directorships |
| 01/04/2019 | Renu Sud Karnad | 00008064 | Director | View other directorships |
| 18/05/2020 | Sunita Maheshwari | 01641411 | Director | View other directorships |
| 01/04/2022 | Juby Chandy | 09530618 | Whole-time director | View other directorships |
| 01/04/2022 | Juby Chandy | *****1773F | CFO | |
| 16/05/2022 | Manu Anand | 00396716 | Director | View other directorships |
| 01/12/2022 | Bhushan Arun Akshikar | 09112346 | Managing Director | View other directorships |
Business Network
CompanyDirectorNot on WeeDooBoard seatKey rolePast seatOwnership
Directors 11
- Bhushan Arun AkshikarManaging Director
- Juby ChandyWhole-time director
- Manu AnandDirector
- Sunita MaheshwariDirector
- Renu Sud KarnadDirector
- Subesh Ronald WilliamsDirector
- Anami Narayan Prema RoyDirector
- Pradeep Vasudeo BhideDirector
- Sundaram DamodarannairDirector
- Juby ChandyCFO
- Ajay Avinash NadkarniCompany Secretary
Subsidiaries 1
- Biddle Sawyer LimitedDirect
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 01/08/2024 | Form MGT-7-01082024_signed | - |
| 25/07/2024 | Form AOC-4(XBRL)-25072024_signed | - |
| 21/02/2024 | Form Addendum to AOC-4 CSR-21022024 | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dabur India Limited | L24230DL1975PLC007908 | 8/3 Asaf Ali Road, New Delhi, Delhi, India, 110002 |
| Gujchem Distillers India Limited | L24230GJ1939PLC002480 | - |
| Ind Swift Limited | L24230CH1986PLC006897 | 781industrial Area Phase Ii, Chandigarh, Chandigarh, India, 160002 |
| Lyka Labs Limited | L24230GJ1976PLC008738 | 4801/b & 4802/a Gidc Indutrail Estate, Ankleshwar, Gujarat, India, 393002 |
| Torrent Pharmaceuticals Ltd | L24230GJ1972PLC002126 | Torrent Houseoff Ashram Road Navarangpura 9, Ahmedabad, Gujarat, India, 000000 |
Direct/Ultimate Children
| Type | Legal Name | LEI code |
|---|---|---|
| Direct | Biddle Sawyer Limited | 335800AHVU9SWXODFQ28 |
Address
Gsk House, Dr Annie Besant Road Worli, Mumbai City, Mumbai, Maharashtra, India, 400030
Frequently Asked Questions
What is the incorporation date of Glaxosmithkline Pharmaceuticals Limited?
The incorporation date of Glaxosmithkline Pharmaceuticals Limited is 12/11/1924.
What is the authorized share capital and paid-up capital of Glaxosmithkline Pharmaceuticals Limited?
The authorized share capital of Glaxosmithkline Pharmaceuticals Limited is ₹1,80,00,00,000.00. The paid-up capital is ₹1,69,40,60,340.00.
Who are the current board members & directors of Glaxosmithkline Pharmaceuticals Limited?
The current board member of Glaxosmithkline Pharmaceuticals Limited are:
- Subesh Ronald Williams
- Renu Sud Karnad
- Sundaram Damodarannair
- Anami Narayan Prema Roy
- Pradeep Vasudeo Bhide
- Sunita Maheshwari
- Manu Anand
- Juby Chandy
- Bhushan Arun Akshikar
What is the registered address of Glaxosmithkline Pharmaceuticals Limited?
The registered address of Glaxosmithkline Pharmaceuticals Limited is Gsk House, Dr Annie Besant Road Worli, Mumbai City, Mumbai, Maharashtra, India, 400030.
What is the Corporate Identification Number of Glaxosmithkline Pharmaceuticals Limited?
The Corporate Identification Number of Glaxosmithkline Pharmaceuticals Limited is L24239MH1924PLC001151.